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network with autoencoders 
to predict the survival chance 
of COVID‑19 patients
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Afshin Shoeibi5,6, Roohallah Alizadehsani1*, Juan M. Gorriz7,8, Sadiq Hussain9, 
Zahra Alizadeh Sani10, Hossein Moosaei11, Abbas Khosravi1, Saeid Nahavandi1 & 
Sheikh Mohammed Shariful Islam12,13,14
COVID‑19 has caused many deaths worldwide. The automation of the diagnosis of this virus is highly 
desired. Convolutional neural networks (CNNs) have shown outstanding classification performance 
on image datasets. To date, it appears that COVID computer‑aided diagnosis systems based on 
CNNs and clinical information have not yet been analysed or explored. We propose a novel method, 
named the CNN‑AE, to predict the survival chance of COVID‑19 patients using a CNN trained with 
clinical information. Notably, the required resources to prepare CT images are expensive and limited 
compared to those required to collect clinical data, such as blood pressure, liver disease, etc. We 
evaluated our method using a publicly available clinical dataset that we collected. The dataset 
properties were carefully analysed to extract important features and compute the correlations of 
features. A data augmentation procedure based on autoencoders (AEs) was proposed to balance the 
dataset. The experimental results revealed that the average accuracy of the CNN‑AE (96.05%) was 
higher than that of the CNN (92.49%). To demonstrate the generality of our augmentation method, 
we trained some existing mortality risk prediction methods on our dataset (with and without data 
augmentation) and compared their performances. We also evaluated our method using another 
dataset for further generality verification. To show that clinical data can be used for COVID‑19 survival 
chance prediction, the CNN‑AE was compared with multiple pre‑trained deep models that were tuned 
based on CT images.
Currently, medical centres hold huge amounts of patient data. Medical biomarkers, demographic data and image 
modalities can help and support medical specialists to diagnose infectious  diseases1, Alzheimer’s2,  Parkinson3 
and coronary artery  disease4. However, these data must be processed and analysed if they are to become usable 
information for specialists. Automated solutions based on artificial intelligence have the potential to carry out 
the required process  efficiently5.
Recently, a new type of coronavirus (i.e., Coronavirus Disease 2019 [COVID-19]) emerged, which has taken 
many lives  worldwide6–9. The virus outbreak was observed for the first time in late  201910,11. COVID-19 primarily 
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targets the  lungs12,13. Thus, if the virus is not properly diagnosed in the early stages of infection, it can severely 
damage the  lungs14. The mortality rate of the virus is low; however, it must not be overlooked, as the virus is 
highly contagious. The virus threat becomes more serious when the resources of medical centres cannot provide 
services to the large number of people who are infected each  day15.
The prediction of the survival chance of infected individuals is as important as the early detection of the virus. 
Under resource scarcity, medical centres can take into account patients’ conditions and use the available resources 
wisely. Previous research on COVID-19 detection has proven that deep neural networks are very effective in the 
early detection of COVID-1916. Thus, it may be that deep networks are also useful for survival chance prediction. 
In this study, we relied on a clinical dataset, which included data about gender, age and blood type, to perform 
a diagnostic analysis of the COVID-19 virus. To the best of our knowledge, this appears to be the first paper to 
propose a survival chance predictor for COVID-19 patients using clinical features. To evaluate the effectiveness 
of our proposed method, we compared its performance against a standard convolutional neural network (CNN) 
trained on image data. This study makes a number of contributions as follows:
• The survival chance prediction of COVID-19 patients based on clinical features
• Preparing clinical dataset to predict the survival chance of COVID-19 patients for the first time
• Providing a careful analysis of the dataset characteristics, including an examination of the effects of features 
on the mortality rate and the correlations between each feature pair
• Making our dataset publicly available
• Combining Autoencoder (AE) with CNN to increase prediction accuracy
• Proposing a data augmentation procedure to balance the number of samples of different classes of the dataset. 
Notably, our data augmentation method is generic and applicable to any other dataset.
The remaining sections of the paper are organised as follows: “Literature review” reviews the related literature; 
“Background” briefly sets out the required background; “Description of our clinical dataset” describes our dataset; 
“Proposed methodology” explains the proposed methodology; “Experiments” presents our experimental results; 
and “Discussion” and “Conclusions and future works” present our discussion, conclusion and future works.
Literature review
This study sought to predict the survival chance of COVID-19 patients using clinical features. We began by 
reviewing the COVID-19 detection methods that rely on clinical features and image data. We also reviewed 
methods on mortality estimations of infected patients.
To contain the COVID-19 threat as soon as possible, researchers approached this virus from multiple direc-
tions. Some focused on the fast and accurate detection of infected patients. For example, Wu et al.17 extracted 11 
vital blood indices using the random forest (RF) method to design an assistant discrimination tool. Their method 
had an accuracy of 96.97% and 97.95% for the test set and cross-validation set, respectively. The assistant tool was 
well equipped to perform a preliminary investigation of suspected patients and suggest quarantine and timely 
treatment. In another study, Rahman et al.18 reviewed various studies on treatment, complications, seasonality, 
symptoms, clinical features and the epidemiology of COVID-19 infection to assist medical practitioners by 
providing necessary guidance for the pandemic. Using a CNN, they tried to detect infected patients to isolate 
them from healthy patients.
Various hybrid approaches have been adopted to improve COVID-19 diagnosis accuracy. Islam et al.19 
employed a CNN for feature extraction and long short-term memory for the classification of patients based on 
X-ray images.  EMCNet20 is another hybrid diagnosis approach that uses a CNN for feature extraction and car-
ries out binary classification using a number of learning techniques, including RF and support vector machine 
(SVM), on X-ray images. Islam et al.21 also used a CNN for feature extraction but relied on a recurrent neural 
network (RNN) for classification based on the extracted features. Multiple experiments have been conducted 
using a combination of architectures, such as VGG19 and DenseNet121, with an RNN. VGG19 + RNN was 
reported to have the best performance.
In addition to distinguishing between infected and non-infected patients, it is also important to determine 
whether infected patients have severe conditions. Muhammad et al.22 relied on data mining to predict the recov-
ery condition of infected patients. Their method was able to determine the age group of high-risk patients who are 
less likely to recover and those who are likely to recover quickly. Their method was able to provide the minimum 
and the maximum number of days required for a patient’s recovery. Chen et al.23 studied 148 severe and 214 
non-severe COVID-19 patients from Wuhan, China using their laboratory test results and symptoms as features 
to design a RF. The task of the RF was to classify COVID-19 patients into severe and non-severe types using the 
features. Using the laboratory results and symptom as input, the accuracy of their model was over 90%. Some 
of the key features they identified were lactate dehydrogenase (LDG), interleukin-6, absolute neutrophil count, 
D-Dimer, diabetes, gender, cardiovascular disease, hypertension and age.
Other researchers have focused on the mortality risk prediction of the patients. Gao et al.24 proposed a mor-
tality risk prediction model for COVID-19 (MRPMC) that applied clinical data to stratify patients by mortality 
risk and predicted mortality 20 days in advance. Their ensemble framework was based on four machine-learning 
techniques; that is, a neural network (NN), a gradient-boosted decision  tree25, a SVM and logistic regression. 
Their model was able to accurately and expeditiously stratify the mortality risk of COVID-19 patients.
Zhu et al.26 presented a risk stratification score system as a multilayer perceptron (MLP) with six dense layers 
to predict mortality. 78 clinical variables were identified and prediction performance was compared with the 
pneumonia severity index, the confusion, uraemia, respiratory rate, BP, age ≥ 65 years score and the COVID‐19 
severity score. They derived the top five predictors of mortality; that is, LDH, C‐reactive protein, the neutrophil 
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to lymphocyte ratio, the Oxygenation Index and D‐dimer. Their model was proved to be effective in resource‐
constrained and time‐sensitive environments.
The power of the XGBoost algorithm has also been leveraged for mortality risk prediction. For example, 
Yan et al.27 collected blood samples of 485 infected patients from China to detect key predictive biomarkers of 
COVID-19 mortality. They employed a XGBoost classifier that was able to predict the mortality of patients with 
90% accuracy more than 10 days in advance. In another study, Bertsimas et al.28 developed a data-driven mor-
tality risk calculator for in-hospital patients. Laboratory, clinical and demographic variables were accumulated 
at the time of hospital admission. Again, they applied XGBoost to predict the mortality of patients. Adopting 
a different approach, Abdulaal et al.29 devised a point-of-admission mortality risk scoring system using a MLP 
for COVID-19 patients. The network exploited patient specific features, including present symptoms, smoking 
history, comorbidities and demographics, and predicted the mortality risk based on these features. The mortal-
ity prediction model demonstrated a specificity of 85.94%, a sensitivity of 87.50% and an accuracy of 86.25%.
As the symptoms of different viruses may be similar to some extent, there has been an attempt to distinguish 
different viruses from one  another30. To this end, multiple classical machine-learning algorithms were trained to 
classify textual clinical reports into the four classes of Severe acute respiratory syndrome (SARS), acute respira-
tory distress syndrome, COVID-19 and both SARS and COVID-19. Feature engineering has also been carried 
out using report length, bag of words and etc. Multinomial Naïve Bayes and logistic regression outperformed 
other classifiers with a testing accuracy of 96.2%. A summary of the reviewed works are presented in Table 1.
Most existing studies on COVID-19 have relied on computed tomography (CT) and X-ray images to achieve 
their research objectives. Al-Waisy et al.31 proposed COVID-DeepNet, a hybrid multimodal deep-learning system 
for diagnosing COVID-19 using chest X-ray images. After the pre-processing phase, the predictions from two 
models (a deep-belief network and a convolutional deep-belief network) were fused to improve diagnosis accu-
racy. Another fusion of two models (ResNet34 and a high-resolution network model) was proposed  in32 to form 
the COVID-CheXNet method for COVID-19 diagnosis. Mohammed et al. collected a dataset of X-ray images 
and made it publicly available. The dataset has been used to benchmark various machine-learning methods 
for COVID-19  diagnosis33. They reported that the ResNet50 model achieved the best performance. In another 
benchmarking  study34, 12 COVID-19 diagnostic methods were examined based on 10 evaluation criteria. To 
this end, multicriteria decision making (MCDM) and the technique order of preference by similarity to ideal 
solution were employed. The 10 criteria were weighted based on entropy. The SVM classifier was reported to 
have the best performance among the benchmarked methods.
Slowing down the spread of COVID-19 and supporting infected patients are as important as COVID-19 
detection. Several works have investigated the possibility of using existing technologies to benefit infected 
patients. Rahman et al.35 proposed a deep-learning architecture to determine whether people are wearing a facial 
mask. The monitoring was realised via closed-circuit television cameras in public places. Islam et al.36 reviewed 
existing technologies that can facilitate the breathing of infected patients. Wearable technologies and how they 
can be used to provide initial treatment to people have also been  investigated37. Ullah et al.38 reviewed telehealth 
services and the possible ways in which they can be used to provide patients with necessary treatments while 
keeping the social distance between patients and doctors.
Some works have adopted a broader approach and reviewed various recently developed deep-learning meth-
ods with application to COVID-19 diagnosis. For example, Islam et al.39 reviewed these methods based on X-ray 
and CT images while the overall application of deep learning for diagnosis purposes to control the pandemic 
threat has been discussed  in40.
Based on the review presented above, it is apparent that existing works based on clinical data are rather scarce. 
Thus, we sought to conduct another study using clinical data for mortality risk assessment. The difference between 
our method and existing research on mortality risk assessment is twofold. First, we developed a new approach 
for carrying out the assessment. Second, some of the clinical features that we considered had never been used 
previously, which is why we have released our dataset publicly. As will be discussed further below, clinical data 
are more cost effective than CT images, and classifiers trained on clinical data achieve a level of performance 
that is almost equal to that achieved by classifiers trained on CT images. To justify this claim, we compared the 
performance of our method trained on clinical data to a standard CNN trained on CT images.
Table 1.  Summary of the reviewed literature.
Ref Method Objective
Gao et al.24 An Ensemble of NN, grad boosted decision tree, SVM, and logistic regression Mortality risk prediction
Zhu et al.26 MLP Mortality risk prediction
Yan et al.27 XGBoost classifier Mortality risk prediction
Bertsimas et al.28 XGBoost classifier Mortality risk prediction
Abdulaal et al.29 MLP Mortality risk prediction
Wu et al.17 RF COVID-19 detection
Rahman et al.18 CNN COVID-19 detection
Khanday et al.30 Multinomial Naïve Bayes and Logistic regression Patients classification into four classes {SARS, ARDS, COVID-19, Both (SARS, COVID-19)}
Chen et al.23 RF COVID-19 severity classification
4
Vol:.(1234567890)
Scientific Reports |        (2021) 11:15343  | https://doi.org/10.1038/s41598-021-93543-8
www.nature.com/scientificreports/
Background
Our proposed method comprises two modules: the classifier and data augmenter. The classification is carried 
out using a CNN. The data augmentation is realised using 10 AEs. In this section, we briefly review the main 
concepts of CNNs and AEs.
CNNs. CNNs are massively used in image-based learning applications. Due to the automatic feature extrac-
tion mechanism of CNNs, they can discover valuable information from training samples. CNNs are usually 
designed with several convolutional, pooling and fully connected  layers41. As Fig. 1 shows, feature extraction is 
done by convolving the input with convolutional kernels. The pooling layer reduces the computational volume 
of the network without making a noticeable change in the resolution of the feature map. In CNNs, the size of 
the pooling layers usually decreases as the number of layers increases. Two of the most popular types of pooling 
layers are max pooling and average  pooling42.
AEs. AEs belong to the realm of unsupervised learning, as they do not need labelled data for their training. 
In brief, an AE compresses input data to a lower dimensional latent space and then reconstructs the data by 
decompressing the latent space representation. Similar to principle component analysis (PCA), AEs perform 
dimensionality reduction in the compression phase. However, unlike PCA, which relies on linear transforma-
tion, AEs carry out nonlinear transformation using deep neural  networks43. Figure 2 shows the architecture of 
a typical AE.
Information gain. In this section, we review information gain (IG), as it is used to determine the degree to 
which each feature of our dataset contributes to the patients’ deaths (see “Description of our clinical dataset”). 
IG calculates the entropy reduction that results from splitting a dataset, D , based on a given value, a , of a random 
variable, A , such that:
where H(D) and H(D|A = a) are entropy on dataset D and conditional entropy on dataset D , respectively, given 
that A = a.
Conditional entropy is computed as:
IG(D, A = a) = H(D)−H(D|A = a),
Figure 1.  A CNN schematic.
Figure 2.  AE architecture: high-dimension input data are encoded (compressed) to form a latent (hidden) 
space that has a lower dimension than that of the original input. The latent representation is reconstructed 
(decoded) to yield decompressed output.
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where DA= a ⊂ D is the set of samples with variable A = a and |DA=a| and |D| denote the cardinality of subset 
DA = a and set D , respectively. In Eq. (1), the sum is computed over all possible values of A.
Description of our clinical dataset
The dataset we collected in this paper comprised 320 patients (300 cases of recovered patients and 20 cases of 
deceased patients). The percentage of female cases was 55%. The mean age of patients in the dataset was 49.5 years 
old, and the standard deviation was 18.5. The patients referred to Tehran Omid hospital in Iran from 3 March 
2020 to 21 April 2020. Ethical approval for the use of these data was obtained from the Tehran Omid hospital. 
In gathering the data, patients’ history (as collected by doctors), questionnaires (as completed by patients), 
laboratory tests, and vital sign measurements were used. Descriptions of the dataset features are presented in 
Table 2. Our dataset is publicly available  in44. Institutional approval was granted for the use of the patient datasets 
in research studies for diagnostic and therapeutic purposes. Approval was granted on the grounds of existing 
datasets. Informed consent was obtained from all of the patients in this study. All methods were carried out in 
accordance with relevant guidelines and regulations.










Blood type {A−, A + , B-, B + , AB-, AB + , O-, O +}
BCG vaccine {Yes, No}
CBC {Normal, Abnormal}
Diabetes {Yes, No}
Blood pressure {Yes, No}
Asthma {Yes, No}
Heart disease {Yes, No}
Kidney disease {Yes, No}






Liver disease {Yes, No}
Rheumatological disease {Yes, No}
Chest pain {Yes, No}
Fever {Yes, No}
Trembling or shakes {Yes, No}
Weakness {Yes, No}
Sweating {Yes, No}
Sore throat {Yes, No}
Dyspnea {Yes, No}
Dry cough {Yes, No}
Cough with sputum {Yes, No}





Conjunctivitis (Pink eye) {Yes, No}
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As our dataset had not been released previously, it was vital to assess the degree to which each dataset feature 
contributed to patients’ deaths. Such an analysis provides researchers with valuable insights into the characteris-
tics of the collected data. Various feature selection methods are available to determine the weight of each feature 
in the classification of dataset samples. We chose  IG45, which is one of the most widely used feature selection 
 methods46. In Fig. 3, the importance of each feature (i.e., the IG) is shown as a bar. Age had a much larger IG 
(0.149) than other features. Thus, age was not included in Fig. 3 to make it easier to compare the importance 
of the other features. According to the bar chart, (after age) cancer, heart and kidney diseases were the second, 
third and fourth most important features related to patients’ deaths, respectively. Thus, it was clear that patients 
with poor health conditions were more vulnerable to COVID-19. It should be noted that Fig. 3 does not include 
the features with zero IG.
We also inspected the interplay between the dataset features to determine the potential correlation between 
them. To this end, the grid in Fig. 4 is presented. Figure 4 can be thought as a heat map that shows the positive/
negative correlation between features. Each cell c(i, j) in the grid of Fig. 4 represents the correlation of features 
in the i-th row and j-th column. As the cell colour approaches red, the positive correlation between the feature 
pairs is higher. For example, anosmia (the loss of the ability to smell) and ageusia (the loss of the ability to taste 
with the tongue) had a high positive correlation, which means they were usually observed simultaneously.
Proposed methodology
This study investigated the survival chance prediction of COVID-19 patients who referred to the Omid hospital 
in Tehran. The classification was based on features obtained from patients’ information. In the dataset collected, 
the number of recovered patients was 300 and the number of deceased patients was 20. The number of recovered 
patients was clearly much higher than that of the deceased patients. To ensure accurate classification, it was neces-
sary to balance the recovered to the deceased ratio of the dataset samples. To do this, the number of instances of 
the lower class was increased, such that the number of data in both classes was approximately equal. To increase 
the number of data of deceased patients, an AE model was used. To carry out the data augmentation, the 20 
samples of the deceased class were fed to the AE to undergo the compression and decompression routines. The 
output of this process comprised 20 reconstructed samples that were similar (but not identical) to the original 
ones. Thus, we augmented the original 20 samples with 20 reconstructed samples. Training the AE 10 times using 
different training and validation sets yielded 10 AEs with a similar architecture but different parameters. Each of 
the 10 AEs generated 20 reconstructed deceased samples, yielding reconstructed samples of 200 overall, which 
were added to the original deceased samples. To provide an insight into the function of the AEs, sample vectors 
before and after reconstruction are presented in Table 3. For the majority of ‘1’ elements of input vector c , the AE 
Figure 3.  Feature effects on mortality rate based on IG.
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outputted values near 1 as the elements of reconstructed vector ĉ  . Similarly, most of the reconstructed elements 
corresponding to original ‘0’ elements had values near ‘0’, which shows that the reconstruction process was sound.
The details of the augmentation process are explained in more detail in Subsection 5.1. It should be noted 
that our augmentation procedure is generic and can be applied to any other dataset.
Implementation details of CNN‑AE. The proposed CNN-AE method comprises multiple steps (see 
Fig. 5 for a summary). The pseudo-code of the method is also available in Algorithm 1. The detailed explanation 
of the pseudo-code is presented below:
1. 10 AEs {AE1, . . . , AE10} were designed with identical configuration but different initial parameters for 
data augmentation (line 1).
2. Each of the 10 AEs was trained on 300 samples representing the recovered patients. Our objective was to have 
10 models with different parameters at the end of the training. To this end, we divided the 300 samples into 10 
groups of 30 samples {gj , j = 1, 2, . . . , 10} where gj is the j-th group of samples. To train the i-th model, 
gi was set aside for validation and the nine remaining groups { gj , j ∈ {1, 2, . . . , 10} − {i}} (270 samples) 
were used for training. It should be noted that each model was initialised with different parameters, trained 
on partially different training samples and validated on a totally different validation set. Thus, the proposed 
training procedure yielded 10 different AEs (lines 2–4).
Figure 4.  Correlation between dataset features.
Table 3.  An example of reconstruction performed by an AE: vector c is the original sample and vector ĉ  is its 
reconstructed counterpart.
c[1 : 10] 1 0 0 1 0 0 0 0 0 0
ĉ[1 : 10] 0.9940 0.1291 0.0001 0.4697 0.1581 0.0240 0.0525 0.0068 0.0061 0.0202
c[11 : 20] 0 0 0 1 0 0 0 0 1 1
ĉ[11 : 20] 0 0 0.0003 0.4004 0.0004 0.0596 0.0040 0.0027 0.9516 0.4450
c[21 : 30] 0 0 0 1 1 0 1 0 0 0
ĉ[21 : 30] 0.1305 0.0018 0.0042 0.9565 0.5750 0.0029 0.9281 0.0111 0.0140 0.0966
c[31 : 39] 0 0 0 0 0 0 0 0 1 -
ĉ[31 : 39] 0.0087 0.0004 0 0.0110 0.0024 0 0.0017 0.0015 0.9814 -
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3. The 20 deceased samples were fed to each of the 10 trained AEs. The samples underwent the compression 
and decompression routine of the AEs. As the decompression procedure was lossy, the 20 reconstructed 
samples (after decompression) were not identical to the original samples. Additionally, the 10 trained AEs 
exhibited different behaviours on the same input data, as their parameters were different from each other. 
Thus, feeding the same 20 samples to the 10 AEs yielded 200 new samples that belonged to the deceased class 
(lines 5–8). The explained procedure sought to augment the data to remedy the lack of sufficient samples for 
the deceased class.
4. The 200 reconstructed samples were attached to 320 original samples to yield a dataset of 520 samples (line 
9).
5. A CNN model was designed to classify 520 samples as recovered or deceased (line 10).
6. The CNN model was trained using all 520 samples. A tenfold cross-validation was applied during the train-
ing (lines 11–20). Thus, the training sample size was 468 (samples of 9 folds), and the test sample size was 
52 (samples of onefold).
7. The trained CNN was used to classify the test data (line 21).
Algorithm 1. CNN-AE pseudo-code
Input: dataset D = {Drecovered ∪ Ddeceased }, training epochs N, batch size B, number of folds K
// Auto-encoders initialization
1:
Create 10 autoencoders with initial random parameters: 
{ AE1, . . . ,AE10}
// Autoencoders training
2: Partition samples in Drecovered to 10 subsets:{g1, . . . , g10}
3: For i = 1:10
4:
   Train AEi on Drecovered − gi and perform validation on gi
// Augmented data generation
5: A = []
6: For i = 1:10
7:    ai = AEi(Ddeceased)
Figure 5.  The steps for implementing the proposed method.
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Algorithm 1. CNN-AE pseudo-code
Input: dataset D = {Drecovered ∪ Ddeceased }, training epochs N, batch size B, number of folds K
// Auto-encoders initialization
8:    A = A ∪ ai
9: Daugmented = D ∪ A
10: Create CNN C with initial random parameters
11: // K-Fold cross validationPartition Daugmented to 90% training set Dtrain and 10% test set Dtest
12: Partition Dtrain to K subsets {F1, . . . , FK }
13: For k = 1:K
14:    Dtrain = Daugmented − FK
15:    Dvalid = FK
16:    For e = 1:N
17:       batcht = sample_batch(Daugmented ,B)
18:       CNN.train(batcht)




To implement the proposed method, we used Python language and the Keras library, which has a TensorFlow 
backend. In this study, the dataset contained 320 samples of infected cases. Of these 320 cases, the number of 
recovered cases was 300, and the number of deceased cases was 20. Additionally, we also generated 200 recon-
structed deceased cases to balance the recovered to the deceased ratio of our dataset. After the reconstruction 
phase, our dataset contained 520 cases. We used a tenfold cross-validation. Additionally, 80% of 9 of the folds 
were used for training, and the remaining 20% was used for validation. The implementation details of CNN and 
AE are illustrated in Figs. 6 and 7, respectively.
Experiments
In this section, the experimental results are presented. The implementation details of CNN and AEs are explained 
in “Experimental details”. We report on the performance of the proposed method (CNN-AE) and compare it to 
a CNN in “Experimental results”.
Figure 6.  Implementation details of CNN. ‘CL’ and ‘Dense’ represent convolutional and fully connected 
layers, respectively. Circles with the letter ‘B’ represent batch normalisation layers, and circles with the letter ‘D’ 
represent dropout layers with a probability 0.5.
Figure 7.  The implemented AE: The 39-dimensional input vector was compressed to a 32-dimensional vector. 
During reconstruction, the 32-dimensional vector was decompressed to a 39-dimensional vector.
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Experimental details. Our experiments consisted of two scenarios. In the first scenario, our CNN-AE 
method was compared to a standard CNN method that was trained on clinical data. The architecture of the CNN 
is presented in Table 4. To ensure a fair comparison, we used the same CNN architecture in our method. The 
implementation details of the AEs used in the CNN-AE are presented in Table 5.
In the second phase of our experiments, we compared the CNN-AE trained on clinical data to a standard 
CNN trained on image data. The CNN architecture is presented in Fig. 8. After multiple trials, we obtained the 
best set of the CNN hyperparameters (see Table 6).
Table 4.  Implementation details of the CNN trained on clinical data.
Hyper-parameters Values
Input dimension 39× 1(39 medical features)
Number of convolutional layers 3
Number of fully connected layers 3
Number of filters for each convolutional layer 256
Size of convolutional kernels 3× 3
Strides size 1
Activation function for hidden layers ReLU
Activation function of the last layer Sigmoid
Adam hyper-parameters β1 = 0.9, β2 = 0.999
Learning rate 0.001
Loss function Binary cross entropy (BCE)
Number of neurons of fully connected layers 64, 32, 2
Dropout probability 0.5
Number of epochs 100
Table 5.  AE implementation details.
Hyper-parameters Values
Input dimension 39× 1 (39 medical features)
Number of neurons of the first layer 39× 1
Number of neurons of the second layer 32× 1
Number of neurons of the third layer 39× 1
First and second layers activation function ReLU
Third layer activation function Sigmoid
Adam hyper-parameters β1 = 0.9, β2 = 0.999
Learning rate 0.001
Loss function Binary cross entropy (BCE)
Number of epochs 100
Figure 8.  Implementation details of the CNN trained on CT images. ‘CL’ and ‘Dense’ represent convolutional 
and fully connected layers, respectively. Circles with the letter ‘D’ represent dropout layers with a probability 0.5.
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Experimental results. We sought to answer two important questions about the proposed method. First, we 
compared our method performance with a standard CNN trained on clinical data. This experiment examined 
the effects of the proposed data augmentation technique using multiple AEs. We also trained a standard CNN 
for the same purpose (to predict patients’ survival chance) but used CT images. This experiment sought to deter-
mine how well CT images can represent patients’ survival chance using a CNN as the predictor.
Examining the data augmentation approach. As mentioned in “Implementation details of CNN-AE”, we used 
10 AEs to augment the available dataset. Data augmentation is critical to successful training when the number of 
samples from different classes is unbalanced. Data imbalance can defeat any powerful classifier even a state-of-
the-art CNN, which is why we employed the data augmentation technique.
To investigate the effectiveness of our data augmentation procedure, we trained a CNN on the original dataset 
and our CNN-AE on an augmented dataset. The original dataset comprised only 20 samples with the deceased 
label, but had 300 samples with the recovered label. Comparing the 300 to 20 reveals severe data imbalance from 
which the CNN suffered during training (see Table 7). However, using an augmented dataset with 300 recovered 
samples and 220 deceased samples facilitated the CNN training and improved accuracy (see Table 7). Addition-
ally, the area under the curve (AUC) measure of the CNN-AE was almost twice that of the CNN. The specificity 
measure of CNN was almost zero, which was due to the fact that the CNN was unable to distinguish between 
deceased and recovered samples due to the insufficient number of deceased samples in the original dataset. As 
Table 7 shows, the CNN-AE training took more time; however, this was due to the time it took to train the 10 
AEs required for data augmentation.
In Table 7, the CNN-AE method had an average accuracy of 96.05% and thus outperformed the CNN method, 
which had an average accuracy of 92.49%. Additionally, due to the augmented data, our method was able to 
reduce the training/validation loss faster than CNN (as is evident in Fig. 9). Similarly, the CNN-AE reached 
higher accuracy faster than the CNN (see the plots in Fig. 10). During training, our method exhibited great vari-
ation in the validation plots compared to those of the CNN. This is because the CNN quickly overfitted to the 
small number of deceased samples but the CNN-AE had to deal with more versatile augmented samples. Thus, 
the training of the CNN-AE was more difficult, but it achieved better overall performance.
Comparisons with existing deep models trained on image data. In this section, we evaluated the performance 
of various existing deep models that were trained on a dataset of CT images. The CT images were taken from 
the same patients for whom the clinical dataset was collected. Thus, the results of this section reveal how well 
deep models trained on CT images perform compared to a CNN trained on clinical data. It should be noted 
that most of the experiments in the COVID-19 literature revolve around classifying infected and non-infected 
people using CT images. This section sheds some light on how well deep models can predict the survival chance 
of already infected patients based on CT images.
The dataset comprised 2822 CT images of recovered patients and 2269 CT images of deceased patients. The 
CT image dataset size was much greater than the clinical dataset size, as the CT dataset contained multiple images 
for each patient. As the number of samples of the two classes in the dataset was almost balanced, we did not 
apply our data augmentation technique to the CT dataset. Additionally, having multiple images for each patient 
Table 6.  Implementation details of the CNN trained on image data.
Hyper-parameters Values
Number of convolutional kernels of first layer 64
Number of convolutional kernels of second layer 128
Number of convolutional kernels of third layer 256
Size of convolutional kernels 3× 3
Strides size 2
Input dimension 100× 100
Output dimension 2
Number of convolutional layers 3
Number of fully connected layers 2
Activation function for convolutional and fully connected layers ReLU
Activation function of last layer Sigmoid
Adam hyper-parameters β1 = 0.9, β2 = 0.999
Learning rate 0.001
Loss function Binary cross entropy (BCE)
Number of neurons of the fourth layer (fully connected) 256
Number of neurons of fifth layer (fully connected) 128
Dropout probability 0.5
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served as a form of data augmentation. This was not the case for the clinical dataset for which each patient had 
only one value per feature.
In Table 8, the performance metrics for the evaluated deep models are presented as 95% confidence intervals 
(CIs) that have been computed over a tenfold cross-validation. The results in Table 8 show that UNet had the 
best performance among the evaluated methods, followed by Inception Net V3 and DenseNet121, respectively. 
Overall, Table 8 suggests that some of the famous deep models with pre-trained parameters can be tuned via 
training to predict the survival chance of COVID-19 patients based on CT images. A performance comparison 
of the deep models (see Table 8) and the CNN-AE (see Table 7) revealed that a CNN trained on clinical data 
performed on par with various pre-trained deep models which have been tuned via training on CT data. As 
Table 7.  Comparison of the CNN and the CNN-AE using different evaluation metrics based on a tenfold 
cross-validation.
Methods Fold No Accuracy (%) PPV (%) Recall (%) Specificity (%) F1-score (%) AUC (%) Loss Total training time (s)
CNN
1 93.75 94 100 0 97 50 0.2157 27.04
2 93.75 94 100 0 97 50 0.2104 20.48
3 93.75 94 100 0 97 50 0.2733 21.34
4 90.63 97 94 0 95 46.77 0.6140 21.49
5 96.88 97 100 66.67 98 83.33 0.0916 21.70
6 90.63 97 94 0 95 46.77 0.2164 22.00
7 93.75 94 100 0 97 50 0.1642 21.51
8 93.75 94 100 0 97 50 0.1816 21.83
9 81.25 96 81 80 88 80.74 0.7327 21.97
10 96.77 97 100 0 98 50 0.1214 22.75
95% confidence interval over 
10 folds 92.49 ± 2.75 95.40 ± 0.88 96.90 ± 3.73 14.67 ± 19.00 95.90 ± 1.82 55.76 ± 8.54 0.282 ± 0.13 22.21 ± 0.37
CNN-AE
1 98.08 97 100 94.74 99 97.37 0.0925 33.01
2 94.23 94 97 90.91 95 93.79 0.2600 31.50
3 100 100 100 100 100 100 0.0096 31.35
4 96.15 96 96 95.83 96 96.13 0.2600 31.60
5 93.27 91 97 85 94 90.94 0.4017 31.90
6 92.31 94 94 90.48 94 92.01 0.3678 31.99
7 98.08 97 100 95.45 98 97.73 0.0858 32.30
8 96.15 94 100 90.91 97 95.45 0.2027 32.90
9 94.23 92 96 92.59 94 94.3 0.1572 33.13
10 98.04 97 100 95.45 98 97.73 0.0614 33.83
95% confidence interval over 
10 folds 96.05 ± 1.48 95.2 ± 1.63 98 ± 1.33 93.14 ± 2.52 96.5 ± 1.27 95.55 ± 1.70 0.19 ± 0.07 32.35 ± 0.49
Figure 9.  Loss plots of the CNN and CNN-AE methods during the training of our dataset.
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stated above, the CT image dataset size was almost 10 times that of the clinical dataset size. However, the CNN 
trained on clinical data performed almost as well as the deep models trained on CT data. Thus, clinical data could 
be a good replacement for CT training data if the preparation of the CT images would be difficult or expensive.
Comparison with other methods trained on clinical data. In this section, we compare the perfor-
mance of our CNN-AE with some of the existing works on mortality  prediction23,26,27. To this end, we imple-
mented the methods of Chen et al.23, Zhu et al.26 and Yan et al.27. As mentioned above in the literature review, 
Chen et al. relied on the RF to assess the severity of COVID-19 patients. For mortality risk prediction, Zhu 
et al.26 and Yan et al.27 used MLP and XGBoost, respectively. These methods were specifically designed to achieve 
COVID-19-related objectives. For a broader perspective, we also experimented with Naïve Bayes, which is a 
generic method that can be used regardless of the classification objective. The conducted experiments revealed 
that our data augmentation approach was generic and beneficial to any classification method.
Methods’ performance. In this section, we present the experimental results for the classification methods men-
tioned above. We also investigate the effects of using the proposed data augmentation technique during training. 
The performance statistics are presented as 95% CIs in Table 9. The CIs are computed based on tenfold cross-
validation. First, each method was trained on the original dataset (without augmentation). The training was 
repeated using the augmented dataset. The proposed data augmentation using AEs was used for this purpose. 
All of the rows in Table 9 that are related to training on the augmented dataset are marked with ‘ + AE’ postfix in 
the ‘Methods’ column. The last row of Table 9 is identical to the last row of Table 7, which has been reproduced 
here for ease of reference. An inspection of the results in Table 9 reveals that the proposed CNN-AE method 
outperformed the other methods in terms of accuracy, recall and AUC. Yan et al.27 + AE, Chen et al.23 + AE and 
Zhu et al.26 + AE claimed second, third and fourth places, respectively. Thus, all methods have clearly benefitted 
from the augmentation performed on the training dataset. Among the evaluated methods, Naïve Bayes had the 
worst performance; however, it also benefitted from the augmented dataset.
Figure 10.  Accuracy plots of the CNN and CNN-AE methods during training of our dataset.
Table 8.  Results of existing deep models trained on CT images.
Method Accuracy (%) PPV (%) Recall (%) Specificity (%) F1-score (%) AUC (%) Loss
CNN 98.88 ± 1.09 98.90 ± 1.07 98.90 ± 0.91 98.10 ± 1.22 98.90 ± 0.87 98.89 ± 0.92 0.01 ± 0.01
DenseNet12147 99.10 ± 0.10 99.00 ± 1.55 99.60 ± 0.60 98.95 ± 0.36 99.20 ± 0.82 99.05 ± 1.10 0.06 ± 0.07
EfficientNet-B148 55.67 ± 1.81 56.70 ± 3.32 95.40 ± 9.02 50.36 ± 2.45 70.00 ± 2.34 51.16 ± 2.08 9.34 ± 5.85
InceptionNet  V349 99.16 ± 1.26 99.80 ± 0.39 98.90 ± 1.95 99.65 ± 0.22 99.40 ± 0.98 99.27 ± 1.02 0.32 ± 0.61
MobileNet50 75.33 ± 1.62 80.70 ± 2.30 73.10 ± 1.66 79.56 ± 1.48 76.60 ± 1.83 75.58 ± 1.75 0.51 ± 0.02
ResNet5051 81.63 ± 1.05 80.50 ± 1.38 88.00 ± 1.01 78.36 ± 1.74 84.20 ± 1.05 80.84 ± 1.06 0.46 ± 0.01
VGG1952 98.02 ± 0.36 99.00 ± 0.30 97.30 ± 0.72 98.79 ± 0.81 98.40 ± 0.43 98.08 ± 0.35 0.07 ± 0.01
Xception53 83.34 ± 0.81 93.80 ± 1.20 74.90 ± 0.85 88.64 ± 0.92 83.10 ± 0.94 84.36 ± 0.86 0.36 ± 0.01
UNet54 99.25 ± 0.21 99.80 ± 0.26 99.70 ± 0.30 98.97 ± 0.19 99.70 ± 0.30 99.66 ± 0.20 0.02 ± 0.01
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Feature selection analysis. In this section, we examine whether feature selection improves the classifica-
tion performance of the clinical dataset. We relied on meta-heuristic population-based algorithms to carry out 
feature selection. The meta-heuristic methods that have been used in the experiments are Artificial Bee Colony 
(ABC)55, Ant Colony Optimisation (ACO)56, Butterfly Optimisation Algorithm (BOA)57, Elephant Herding 
Optimisation (EHO)58, Genetic Algorithm (GA)59 and Particle Swarm Optimisation (PSO)60. Details of the 
implementation of these methods are available in  MEALPY61, which is a Python module consisting of meta-
heuristic algorithms. In all of the experiments detailed in this section, the meta-heuristic methods were run for 
500 epochs with a population size of 100.
The results of running each of the meta-heuristic methods listed above was a set of selected features (see 
Table 10) that specified a subset of the clinical dataset. The dataset extracted subset was used to train a CNN for 
survival chance prediction. The training was performed with and without data augmentation. The results of the 
training are presented in Table 11. In each row of the table, the meta-heuristic method used for feature selection 
and the classifier is specified. Usage of data augmentation is denoted by ‘–AE’.
As Table 11 shows, regardless of the feature selection method, the CNN-AE trained on the selected features 
did not outperform the CNN-AE trained on the full dataset (see the last row of Table 7). This is because the 
CNN already included an automatic feature selection mechanism and could rule out unnecessary features dur-
ing learning. Discarding some of the features via feature selection only deprived the CNN of the opportunity to 
choose the features that best fit its objective.
Among the evaluated feature selection methods in Table 11, BOA showed the best performance, followed 
by the ACO and ABC, respectively. In relation to Table 11, it should be noted that data augmentation after the 
application of all of the feature selection methods yielded better results. Thus, the proposed data augmentation 
approach is generic.
Discussion
This paper focused on survival chance prediction for COVID-19 patients. We performed experiments using 
both a clinical dataset and a CT image dataset. The size of the CT image dataset was almost 10 times that of the 
clinical dataset. However, the CNN trained on clinical data performed almost as well as the CNN trained on CT 
data, which supports the use of clinical data as an alternative for CT images.
Another aspect that might encourage the use of clinical training samples relates to data collection costs. Pre-
paring CT data may require high-end facilities; however, such facilities may increase data collection costs. Addi-
tionally, the facilities required to prepare CT data may not be available in deprived areas. Conversely, the tools 
required to measure clinical data, such as blood pressure, fever and C-reactive protein, are generally accessible.
The proposed method can detect the severity of patients’ conditions based on clinical data and enable preven-
tive actions to be taken to minimise the mortality rate. As discussed in “Literature review”, very few methods 
have studied mortality rate prediction using clinical data. Additionally, existing methods have used features that 
differ from the ones we used in our experiments. Thus, the proposed method sheds some light on unexplored 
aspects of the COVID-19 virus. To implement the proposed system in practice, it must be evaluated by medical 
experts from medical centres in different regions. After being verified, the system could be used to help experts 
analyse the severity condition of COVID-19 patients. Thus, patients with critical conditions could be given higher 
treatment priority than non-critical patients. Prioritising the patients’ treatment is of the utmost importance 
when the medical resources available are limited.
In addition to the proposed method, our dataset can be considered the second contribution of this paper, 
as it is a good resource for further medical research. The analysis of the importance of the dataset features and 
their correlations are shown in Figs. 3 and 4. Using our dataset, experts can study the relationships between 
patients’ medical conditions (e.g., blood pressure and diabetes) and the likelihood of dying from COVID-19. 
This will enable medical experts to exercise more caution during the treatment of patients who are more likely 
to die due to their medical conditions. As the IG values in Fig. 3 suggest, there is a strong relationship between 
the mortality rate of COVID-19 patients and the presence of other critical diseases, such as cancer, kidney and 
heart diseases. Conversely, mild symptoms and/or diseases, such as dyspnoea, conjunctivitis and asthma, are 
less likely to contribute to the mortality rate.
Table 9.  Performance metrics for various classification algorithms with and without AE-based data 
augmentation.
Methods Rank Accuracy (%) PPV (%) Recall (%) Specificity (%) F1-score (%) AUC (%)
Chen et al.23 7 90.25 ± 3.30 93.60 ± 2.67 96.30 ± 2.50 86.96 ± 2.90 94.70 ± 1.83 49.82 ± 3.15
Chen et al.23 + AE 3 95.38 ± 1.40 94.50 ± 1.58 98.00 ± 1.49 92.86 ± 1.65 96.10 ± 0.94 94.61 ± 2.11
Zhu et al.26 6 91.85 ± 1.86 94.50 ± 2.25 97.50 ± 1.21 89.05 ± 1.89 95.90 ± 1.03 58.67 ± 10.40
Zhu et al.26 + AE 4 92.97 ± 2.14 97.60 ± 1.10 90.80 ± 4.39 95.06 ± 3.26 93.90 ± 2.01 93.81 ± 1.73
Yan et al.27 5 92.50 ± 2.45 94.40 ± 2.32 98.00 ± 1.80 88.67 ± 2.04 95.90 ± 1.29 59.17 ± 9.92
Yan et al.27 + AE 2 95.38 ± 1.28 94.50 ± 2.03 97.90 ± 2.33 91.68 ± 1.85 96.00 ± 1.20 95.23 ± 1.19
Naïve Bayes 9 61.73 ± 6.93 14.30 ± 0.68 88.00 ± 5.65 42.65 ± 5.95 23.90 ± 2.39 74.39 ± 5.68
Naïve Bayes + AE 8 74.92 ± 5.49 63.80 ± 0.89 96.40 ± 3.47 60.74 ± 4.45 76.50 ± 4.29 78.46 ± 4.92
CNN-AE 1 96.05 ± 1.48 95.20 ± 1.63 98.00 ± 1.33 93.13 ± 2.52 96.50 ± 1.27 95.54 ± 1.70
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Table 10.  Selected features by various meta-heuristic methods: (√) selected feature, (×) discarded feature.
Feature Name ABC ACO BOA EHO GA PSO
CBC √ √ √ × √ ×
Blood Type √ √ × √ √ √
Age √ √ √ √ √ √
Diabetes √ √ × √ × √
Blood pressure √ √ × × √ √
Asthma √ √ √ × √ √
Heart disease √ √ √ √ √ √
kidney disease √ √ √ √ √ √
Respiratory disease √ √ × × √ ×
Cancer √ √ × × √ √
Corticosteroids × √ √ √ √ ×
BCG Vaccine √ √ √ √ × √
Transplant √ × × √ √ ×
HEM √ √ √ √ √ √
Immunodeficiency √ √ × × √ √
Liver disease √ √ √ × √ √
Rheumatological disease √ √ × √ √ √
Chest pain √ √ √ √ √ √
Fever √ √ × × √ √
Trembling or Shakes √ × √ × √ ×
Weakness × √ √ √ × √
Sweating √ √ √ √ √ √
Sore throat √ √ √ × √ √
Dyspnea × √ √ √ √ √
Dry cough √ √ √ √ √ √
Cough with sputum √ √ √ √ √ √
Fatigue, whole body hurts × × √ √ √ √
Anosmia √ √ √ × √ √
Ageusia √ √ × × √ √
Anorexia √ √ √ √ √ √
Eczema √ √ √ √ √ √
Conjunctivitis (Pink eye) √ √ √ × √ √
Blindness and Tunnel vision × × × × × ×
Vertigo √ √ √ √ √ √
Nausea/diarrhea √ √ √ √ √ √
Tobacco × √ √ √ × √
Gender √ × √ × √ √
Table 11.  CNN and CNN-AE performance trained on features selected by meta-heuristic methods.
Methods Rank Accuracy (%) PPV (%) Recall (%) Specificity (%) F1-score (%) AUC (%) Loss
ABC + CNN 8 92.32 ± 1.96 94.70 ± 1.06 97.40 ± 2.23 89.65 ± 1.56 96.00 ± 1.20 53.29 ± 5.79 0.25 ± 0.03
ABC + CNN-AE 3 94.61 ± 1.97 95.80 ± 2.51 95.30 ± 2.37 92.92 ± 2.06 95.30 ± 1.60 94.80 ± 1.95 0.24 ± 0.12
ACO + CNN 7 93.10 ± 1.72 95.60 ± 1.44 97.30 ± 1.92 90.57 ± 1.87 96.40 ± 0.98 62.50 ± 11.63 0.26 ± 0.10
ACO + CNN-AE 2 94.71 ± 1.75 94.80 ± 1.67 96.30 ± 2.50 91.95 ± 1.85 95.40 ± 1.66 94.66 ± 1.83 0.22 ± 0.12
BOA + CNN 12 91.37 ± 3.08 94.10 ± 2.52 97.00 ± 2.48 87.08 ± 2.97 95.20 ± 1.65 53.50 ± 7.11 0.28 ± 0.08
BOA + CNN-AE 1 94.99 ± 1.68 93.70 ± 2.38 97.20 ± 2.46 90.82 ± 2.06 95.30 ± 1.89 94.64 ± 1.81 0.24 ± 0.09
EHO + CNN 10 91.86 ± 2.91 94.10 ± 2.42 98.00 ± 1.49 85.69 ± 2.07 95.90 ± 1.59 53.15 ± 5.63 0.23 ± 0.07
EHO + CNN-AE 5 93.95 ± 1.90 94.50 ± 2.45 95.00 ± 3.98 91.57 ± 2.74 94.30 ± 1.80 93.91 ± 1.82 0.26 ± 0.10
GA + CNN 9 92.18 ± 2.08 94.80 ± 1.65 97.80 ± 1.57 88.32 ± 1.76 96.10 ± 0.94 57.50 ± 10.13 0.29 ± 0.07
GA + CNN-AE 4 94.24 ± 1.08 94.40 ± 2.17 96.20 ± 1.46 93.06 ± 1.68 95.30 ± 0.83 94.47 ± 1.26 0.26 ± 0.09
PSO + CNN 11 91.85 ± 2.18 95.00 ± 2.71 96.40 ± 2.11 88.17 ± 1.79 95.50 ± 1.25 61.51 ± 11.18 0.28 ± 0.06
PSO + CNN-AE 6 93.86 ± 2.24 94.20 ± 2.87 95.20 ± 3.12 90.39 ± 2.47 94.50 ± 1.94 93.10 ± 2.97 0.22 ± 0.09
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Like any other classification approach, the proposed method has some limitations. Due to the use of multiple 
AEs in the data augmentation phase, the training time of our method was longer than that of a standard CNN. 
Further, standard CNNs receive a single image sample as input and perform feature extraction automatically. 
Conversely, we manually collected multiple clinical features for each patient, and such a process is more difficult 
to manage. Some of the features in our dataset were gathered directly by asking patients; thus, it is possible that 
patients provided incorrect information.
Conclusions and future works
In this paper, we investigated the possibility of training a CNN on clinical data to predict the survival chance of 
COVID-19 patients. To this end, a new dataset consisting of clinical features, such as gender, age, blood pressure 
and the presence of various diseases, was gathered. The first contribution of this paper relates to our decision to 
release the collected dataset for public use. We also analysed the dataset features using IG and correlation. Our 
analysis could aid potential researchers and practitioners with their work on the COVID-19 virus.
To reduce the data imbalance of our dataset, we proposed a novel data augmentation method based on AEs. 
Our data augmentation approach is generic and applicable to other datasets. Based on the proposed data augmen-
tation approach, a novel survival chance prediction method named CNN-AE was presented, which represents 
the second contribution of this paper. Using augmented data for training, the 95% CI for the accuracy, recall 
and specificity of the CNN-AE were 96.05 ± 1.48%, 98.00 ± 1.33% and 93.13 ± 2.52%, respectively. However, a 
CNN trained on a dataset without augmentation yielded an accuracy of 92.49 ± 2.75%, a recall of 95.4 ± 0.88% 
and a specificity of 96.9 ± 3.73%. Thus, it is clear that the CNN-AE benefitted the data augmentation and out-
performed the CNN.
We repeated the CNN training on CT images obtained from the same patients for whom the clinical data 
had been collected. Comparisons of the performances of the methods trained on clinical data and the methods 
trained on CT data revealed that clinical data can be used as an alternative to CT images.
In the future, more data needs to be collected to further assess our proposed approach. The use of other data 
augmentation methods also needs to be investigated and the results compared with our data augmentation 
method.
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